Medy-Tox Inc.
086900.KQFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
171
Cost of Revenue
67
Gross Profit
104
Gross Margin
60.8%
Operating Income
15
Operating Margin
8.9%
Net Income
13
Net Margin
7.4%
EPS (Basic)
$2.00
EPS (Diluted)
$2.00
EBITDA
29
EBITDA Margin
17.1%
2023
12/31/2023
Revenue
166
Cost of Revenue
65
Gross Profit
100
Gross Margin
60.5%
Operating Income
13
Operating Margin
7.8%
Net Income
7
Net Margin
4.4%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
25
EBITDA Margin
14.8%
2022
12/31/2022
Revenue
146
Cost of Revenue
53
Gross Profit
93
Gross Margin
63.6%
Operating Income
35
Operating Margin
23.8%
Net Income
28
Net Margin
19.0%
EPS (Basic)
$4.00
EPS (Diluted)
$4.00
EBITDA
53
EBITDA Margin
36.1%
2021
12/31/2021
Revenue
139
Cost of Revenue
62
Gross Profit
77
Gross Margin
55.4%
Operating Income
26
Operating Margin
18.7%
Net Income
71
Net Margin
50.9%
EPS (Basic)
$11.00
EPS (Diluted)
$11.00
EBITDA
115
EBITDA Margin
82.6%
2020
12/31/2020
Revenue
106
Cost of Revenue
52
Gross Profit
53
Gross Margin
50.6%
Operating Income
-28
Operating Margin
-26.3%
Net Income
-22
Net Margin
-21.0%
EPS (Basic)
$-3.00
EPS (Diluted)
$-3.00
EBITDA
-13
EBITDA Margin
-12.0%